Ramelteon for Treatment of Adult Patients With ADHD-Related Insomnia
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
Primary: We hypothesize a clinically significant improvement in sleep latency, sleep-onset
and total sleep time measures in adults with ADHD when given a trial of Ramelteon compared to
placebo. Secondary:We expect that Ramelteon will show statistically significant improvements
vs. placebo in measures of daytime sleepiness and with no decrement in daytime functioning,
including such specific items as focus and social and occupational functioning.